Description
The COVID-19 pandemic is still being investigated for the range of different political responses that it has engendered. This panel investigates a number of these responses. This includes the bureaucratic adaptation of the care industry in order to facilitate resilience. New imaginaries of crisis have also emerged that move beyond the exception and the everyday to reveal new forms of enduring care. The novel role of particular actors is also being unearthed. This includes the philanthrocapitalists that have influenced social policy in responding to health emergencies. Pharmaceutical companies too as actors within global health were reframed in terms of their control over a life-saving resource. The COVID-19 pandemic still remains a resource for new understandings of global health practices and actors.
